Scientists from Northwestern University to Present New Data on High Efficiency Electroporation of Human Ion Channels


Gaithersburg, MD, February 24, 2016  – MaxCyte® Inc., the leader in driving the next generation of cellbased medicines with scalable, high-performance cell transfection systems, announces that new data on human ion channels generated using its flow electroporation platform will be presented at the 60th Annual Biophysics Meeting by two prominent professors from Northwestern University, Feinberg School of Medicine.


The following are specific details regarding the presentations:


Drug Discovery for Ion Channel XVI

Satellite Meeting of the Biophysical Society 60th Annual Meeting

Speaker: Dr. Alfred George, Jr. Northwestern University Feinberg School of Medicine

Title: Coupling high capacity electroporation with automated patch clamp recording for functional annotation of human ion channel variants

Date: Friday, February 26, 2016

Time: 4:00-4:30 pm

Location: Room 411, Los Angeles Convention Center


MaxCyte User Group at the 60th Annual Biophysical Annual Meeting

Speaker: Dr. Carlos Vanoye Northwestern University Feinberg School of Medicine

Title: High efficiency electroporation of human ion channel variants for automated patch clamp

Date: Sunday, February 28, 2016

Time: 2:30-4:00 PM

Location: Room 513, Los Angeles Convention Center


In addition to the two presentations, MaxCyte scientists will be available for questions in booth 811.


About MaxCyte

MaxCyte is the leader in driving the next generation of cell-based medicines. Flow electroporation, MaxCyte’s cell modification technology, is used for discovery, development, and manufacture of small molecule, biologic, and cell-based therapeutics. The MaxCyte GT® Flow Transfection System, the MaxCyte STX® Scalable Transfection System, and the MaxCyte VLX® Large Scale Transfection System enable the rapid development and consistent production of transfected cells for a broad array of applications.

For more information visit /